Metabolic inhibition reduced action potential duration by 80% in epicardial cells versus 13% in endocardial cells, and peak Ca2+ current by 37% versus 21% (p<0.01).
Does metabolic inhibition affect action potentials and calcium currents differently in endocardial versus epicardial cells?
Metabolic inhibition causes greater depression of the Ca2+ current and action potential shortening in epicardial cells compared to endocardial cells, which may explain ischemia-induced electrophysiological changes.
p-value: p=<0.01
BACKGROUND: Ischemia-induced electrophysiological changes are more prominent in epicardial cells than in endocardial cells. Epicardial action potentials shorten more than endocardial action potentials during ischemia. Since the L-type Ca2+ current plays an important role in the maintenance of action potential duration, we hypothesized that the Ca2+ current is affected more in epicardial cells than in endocardial cells during ischemia. METHODS AND RESULTS: To test this hypothesis, we examined the effect of metabolic inhibition, a major component of ischemia, on action potentials and the Ca2+ current in single cells isolated from the endocardial and epicardial layers of the feline left ventricle. The membrane voltage and current were measured by using the whole-cell mode of the patch-clamp technique. During control periods, action potentials recorded from epicardial myocytes had lower amplitude, a prominent notch between phases 1 and 2, and shorter action potential duration compared with those recorded from endocardial myocytes. However, the amplitude and current-voltage relation of the Ca2+ current were similar in endocardial and epicardial cells at test potentials of -30 to 60 mV elicited from a holding potential of -40 mV. The time course of inactivation of the Ca2+ current also was identical in the two cell types. After 15 minutes of superfusion with glucose-free Tyrode's solution containing 1 mM CN-, action potential duration was reduced by 13 +/- 7% in endocardial cells and by 80 +/- 9% in epicardial cells (p less than 0.01). The peak Ca2+ current was reduced by 21 +/- 9% in endocardial cells and by 37 +/- 6% in epicardial cells (p less than 0.01). CONCLUSIONS: We conclude that enhanced depression of the Ca2+ current may account in part for the greater action potential shortening in epicardial cells during ischemia and metabolic inhibition.
Kimura et al. (Thu,) conducted a other in Ischemia. Metabolic inhibition (glucose-free Tyrode's solution with CN-) vs. Endocardial cells (compared to epicardial cells) was evaluated on Reduction in action potential duration and peak Ca2+ current (p=<0.01). Metabolic inhibition reduced action potential duration by 80% in epicardial cells versus 13% in endocardial cells, and peak Ca2+ current by 37% versus 21% (p<0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: